Skip to main content

Advertisement

Log in

Self-reported treatment adherence in inflammatory bowel disease in Indian patients

  • Original Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Introduction

Non-adherence to medical therapy is emerging as an important determinant of relapse in patients with inflammatory bowel disease (IBD).

Aim

To find the prevalence of and reasons for nonadherence to medical therapy in Indian patients with IBD and its correlation with disease outcome.

Methods

In this cross-sectional study, we checked for adherence to treatment in 127 patients with IBD (117 ulcerative colitis and 10 Crohn’s disease) using a questionnaire that inquired into frequency of missed doses, causes for missed doses, and its relation to relapse of disease.

Results

Of the 127 patients (mean age 42.8 years; 68 women), 103 (81%) were non-adherent to treatment, defined as taking 80% or less of the dose advised. The reasons for non-adherence (not mutually exclusive) were: forgetfulness-98 patients (77%), felt better-18 (14.2 %), high frequency of doses-13 (10.1%), no effect of medications-10 (7.87%), non-availability of medications-3 (2.3%). Non-adherent patients were three times more likely to develop a relapse as compared to those with adherence (OR 3.389, 95% CI 1.29-8.88, p=0.012).

Conclusions

Over 80% of patients with IBD in this survey were non-adherent to medical treatment; forgetfulness was mentioned as the most common cause. Non-adherent patients were more likely to relapse. Patients need to be educated regarding the need for adherence to treatment in IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003;114:39–43.

    Article  PubMed  Google Scholar 

  2. Kane SV, Brixner D, Rubin DT, Sewitch MJ. The challenge of compliance and persistence: focus on ulcerative colitis. J Manag Care Pharm 2008;14:s2–12.

    PubMed  Google Scholar 

  3. Pasternak R. Report of the Adult Treatment Panel III: the 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults. Cardiol Clin 2003;21:393–398.

    Article  PubMed  Google Scholar 

  4. Weiss JJ, Bhatti L, Dieterich DT, et al. Hepatitis C patients’ self-reported adherence to pegylated interferon and ribavirin. Aliment Pharmacol Ther 2008;28:289–293

    Article  CAS  PubMed  Google Scholar 

  5. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003;98:1535–1544.

    Article  PubMed  Google Scholar 

  6. Lopez San Roman A, Bermejo F, Carrera E, Perez-Abad M, Boixeda D. Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig 2005;97:249–257.

    CAS  PubMed  Google Scholar 

  7. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487–497.

    Article  CAS  PubMed  Google Scholar 

  8. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007;167: 540–550.

    Article  PubMed  Google Scholar 

  9. D’Inca R, Bertomoro P, Mazzocco K, Vettorato MG, Rumiati R, Sturniolo GC. Risk factors for non-adherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther 2008;27:166–172.

    PubMed  Google Scholar 

  10. Hawthorne AB, Rubin G, Ghosh S. Review article: Medication non-adherence in ulcerative colitis-strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther 2008; 27:1157–1166.

    CAS  PubMed  Google Scholar 

  11. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007;102:1417–1426.

    Article  PubMed  Google Scholar 

  12. Dewulf Nde L, Monteiro RA, Passos AD, Vieira EM, Troncon LE. Compliance to drug therapy in inflammatory bowel diseases outpatients from a university hospital. Arq Gastroenterol 2007;44:289–296.

    PubMed  Google Scholar 

  13. Farup PG, Hovde O, Halvorsen FA, Raknerud N, Brodin U. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol 1995;30:164–170.

    Article  CAS  PubMed  Google Scholar 

  14. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006;12:239–245.

    PubMed  Google Scholar 

  15. van der Wal MH, Jaarsma T, van Veldhuisen DJ. Noncompliance in patients with heart failure; how can we manage it? Eur J Heart Fail 2005;7:5–17.

    Article  PubMed  Google Scholar 

  16. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003;25: 2958–2971.

    Article  PubMed  Google Scholar 

  17. van Hees PA, van Tongeren JH. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol 1982;4:333–336.

    Article  PubMed  Google Scholar 

  18. Loftus EV Jr. A practical perspective on ulcerative colitis: patients’ needs from aminosalicylate therapies. Inflamm Bowel Dis 2006;12:1107–1113.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Devendra Desai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhatt, J., Patil, S., Joshi, A. et al. Self-reported treatment adherence in inflammatory bowel disease in Indian patients. Indian J Gastroenterol 28, 143–146 (2009). https://doi.org/10.1007/s12664-009-0050-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-009-0050-z

Keywords

Navigation